Dynacure S.A. (DYCU)

Dynacure was planning to go public, but the IPO has been withdrawn.
Stock Price: $15.00 - $17.00
Current IPO price range
Chart not available yet
Data will show when the stock starts trading.
Market Cap 314.81M
Revenue (ttm) n/a
Net Income (ttm) -18.57M
Shares Out 19.68M
EPS (ttm) -0.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About DYCU

Dynacure S.A. is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. We are initially focused on developing treatments for neuromuscular diseases, beginning with myotubular and centronuclear myopathies, or CNM, a group of devastating rare genetic disorders characterized by severe muscle weakness, or myopathy, with shortened life expectancy and significant morbidity. Our lead product candidate, DYN101, is an antisense ol... [Read more...]

Industry Pharmaceutical Preparations
Founded 2016
CEO Stéphane van Rooijen, M.D, M.B.A.
Employees 22
Stock Exchange NASDAQ
Ticker Symbol DYCU
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements


Dynacure S.A. IPO Registration Document (S-1)

Dynacure S.A. has filed to go public with an IPO on the NASDAQ.